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Eye diseaseEvery minute, a child somewhere in the world either becomes, or is
born blind [1]. Despite its rarity, with an approximate global incidence
of 1 per 3000, childhood cataract is one of the most important causes
of preventable childhood blindness [2]. Unoperated cataract blinds chil-
dren and adults. Affected babies and infants can also be irreversibly
blinded by delayed treatment, due to the absence of stimuli during
early-life development of the visual system (deprivational amblyopia).
Blindness impacts negatively not only on the child and their family,
but also on their surrounding society, due to the lifelong support
related-, and lost workforce costs [1].
Globally, we face a shortage of eye specialists with the training nec-
essary to diagnose and treat childhood cataract [3]. This shortage is par-
ticularly acute in lower income countries, but is also a concern in
settings such as the UK [4]. Fast, accurate AI-based diagnosis would im-
prove accessibility to specialist care and effective use of scarce clinical
resource. Itwould also support the training of future specialists, through
standardisation of practice and access to datasets of rare disease images.
In this issue of EClinicalMedicine, Lin and colleagues report the re-
sults of a randomised controlled trial, using an AI-based diagnostic in-
tervention [5]. The Congenital Cataract-Cruiser (CC-Cruiser) was
created using a multi-layered artiﬁcial network inspired by the☆ The author has no competing interests to declare.
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training dataset of over 400 disease images acquired through
biomicroscopic (‘slit lamp’) eye imaging at the time of surgery, and al-
most 500 normal images, CC-Cruiser was taught to identify, stratify,
and strategise treatment for images of childhood cataract [6]. This was
a relatively small learning dataset, but childhood cataract is a relatively
rare disease. In the study presented in this issue, following slit lamp
image acquisition, children were randomised to routine diagnostic clin-
ical examination by a senior consultant (‘attending’) ophthalmologist,
or image uploaded to the cloud-based CC-Cruiser [5]. Children then
underwent ‘gold standard’ diagnostic examination by an expert panel
who reached a consensus on diagnosis and treatment. In comparison
to a senior consultant, the CC-Cruiser had a lower diagnostic accuracy,
but had comparable patient experience scores and required less time
to reach a diagnosis [5].
AI networks trained on hundreds of thousands of clinical images can
outperform experienced clinicians in the image-based diagnosis of skin
or retinal disorders [7,8], butwe have yet to understand howwebest as-
sess the impact of AI-based diagnostics in real-world clinical practice. A
traditional randomised controlled trial of a diagnostic ‘intervention’ (D-
RCT) would randomise participants to different tests, then compare the
ﬁnal clinical outcomes for both groups following the treatment indi-
cated by that test. AI-based diagnosis, however, represents a signiﬁcant
‘paradigm shift’ in clinical care, complicating the design and processes of
D-RCTs.We have no consensus on the proof-of-concept required to per-
mit ethical recruitment to a D-RCT where patients may receive treat-
ment based on the ﬁndings of an AI-based tool. Where there is
sufﬁcient proof, is it ethical to withhold that technology from affected
individuals? Moore's Law (that every year sees a doubling of computer
processing power) suggests that the technology used within a D-RCT
may be obsolete by the time study ﬁndings are reported. Lin and col-
leagues have selected a pragmatic methodology able to add insights to
the acceptability and utility of AI diagnosis of childhood cataract, al-
though one which is still unable to provide a true assessment of the
‘real-world use’ of AI diagnostic algorithms.
In the real world, children with congenital lens opacities are identi-
ﬁed by a health care professional as part of a screening programme, or
based on concerns regarding visual behaviour. Identiﬁcation is followed
by initial assessment by a community-based health care professional.-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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diagnosis and intervention by a specialist team in order to return good
vision. Eye professionals do not use 2-D clinical images in isolation to
stratify or strategise treatment for childhood cataract [3,9]. Thus, the
utility of CC-Cruiser for decisions downstream of cataract detection is
unclear. Unlike ‘live’ biomicroscopic examination performed on the
awake child, biomicroscopic image acquisition for infants and babies
necessitates sedation [5]. Thus, an automated diagnostic pathway for
young children, who constitute the most important population at risk,
would still involve medical input in order to capture images for analysis
by the AI. The growing uptake of smartphone use and evolving imaging
capabilities will change how we 'see' the eye [10]. Macroscopic images
acquired at community level or by parents may generate a dataset for
deep learning algorithms to support truly automated disease screening.
The ‘democratisation of expertise’ offered byAI-based diagnosis is an at-
tractive promise for a rare disabling diseasewhich requires urgent diag-
nosis and treatment from a stretched workforce. The methodological
lessons learnt through this paper from Lin and colleagues, such as the
success with a limited training dataset, the innovative use of a cloud
based diagnostic platform, and a consensus-based gold standard diag-
nosis, should provide important foundations for future work.
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